BrightPath Biotherapeutics Co., Ltd.
4594.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥1,151 | -¥1,168 | -¥1,484 | -¥1,482 |
| Dep. & Amort. | ¥0 | ¥0 | ¥17 | ¥35 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥116 | ¥3 | ¥17 | -¥15 |
| Other Non-Cash | ¥16 | ¥8 | ¥246 | -¥50 |
| Operating Cash Flow | -¥1,250 | -¥1,157 | -¥1,204 | -¥1,512 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥1 | -¥6 | -¥2 | -¥18 |
| Net Acquisitions | ¥0 | ¥0 | ¥0 | ¥0 |
| Inv. Purchases | ¥0 | ¥0 | ¥0 | ¥0 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Inv. Act. | ¥0 | -¥1 | ¥0 | ¥0 |
| Investing Cash Flow | -¥1 | -¥8 | -¥2 | -¥18 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥88 | ¥113 | -¥88 | ¥88 |
| Stock Issued | ¥1,091 | ¥573 | ¥520 | ¥478 |
| Stock Repurch. | -¥1 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Fin. Act. | ¥3 | ¥5 | ¥0 | ¥4 |
| Financing Cash Flow | ¥1,005 | ¥691 | ¥432 | ¥569 |
| Forex Effect | -¥0 | ¥0 | ¥0 | ¥0 |
| Net Chg. in Cash | -¥247 | -¥474 | -¥774 | -¥960 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥1,057 | ¥1,531 | ¥2,305 | ¥3,265 |
| End Cash | ¥810 | ¥1,057 | ¥1,531 | ¥2,305 |
| Free Cash Flow | -¥1,252 | -¥1,165 | -¥1,206 | -¥1,530 |